Current and Future Immunosuppressive Therapies Following Transplantation

Contributors List. I: Introduction. 1. The History of Immunosuppression for Ogan Transplantation; J.C. Hong, B.D. Kahan. 2. Clinical Trials in Transplant Immunosuppression: What Have We Learned? P. Schnuelle, F.J. van der Woude. II: Pharmacological Immunosuppression. 1. Pharmacologic Monitoring of Immunosuppressive Drugs; F. Gaspari, et al. 2. Use of Corticosteroids in Kidney Transplantation; D.E. Hricik. 3. Mycophenolate Mofetil and Azathioprine; J.D. Pirsch, E.D. Neto. 4. Cyclosporine Formulations; V. Ramanathan, H. Helderman. 5. Tacrolimus; R. Shapiro. 6. Sirolimus; B.D. Kahan. 7. New Agents on the Horizon; J. Klupp, R.E. Morris. III: Biologicals. 1. Why Do We Need Induction Therapy? J. Vella, J. Neylan. 2. Polyclonal Antilymphocyte Therapy; P. Morrissey, A.P. Monaco. 3. Monoclonal Antibody Targeting of the T cell Receptor Complex; L. Chatenoud. 4. Monoclonal Antibody Targeting of IL-2R-Complex; F.G. Vincenti. 5. Monoclonal Antibody Targeting of Adhesion Molecules; M.H. Frank, D.M. Briscoe. 6. Costimulation Blocade; R.D. Bloom, L.A. Turka. 7. Immunomodulatory Function of MHC Peptides; B. Murphy, A. Krensky. 8. Tolerance: Is It Time to Move to the Clinic? M.H. Frank, M.H. Sayegh. IV: Gene Therapy. 1. Molecular Medicine in Organ Transplantation: How and When? A. Benigni, et al. 2. Gene Therapy in Organ Transplantation: Applicabilities andShortcomings; J.C. Magee, et al. 3. Immunomodulation Strategies in Xenotransplantation; I.P.J. Alwayn, et al.